Literature DB >> 29674327

Incorporating medication indications into the prescribing process.

Kevin Kron1, Sara Myers2, Lynn Volk1, Aaron Nathan2, Pamela Neri3, Alejandra Salazar2, Mary G Amato4, Adam Wright2,5, Sam Karmiy1, Sarah McCord6, Enrique Seoane-Vazquez7, Tewodros Eguale2,6, Rosa Rodriguez-Monguio8, David W Bates2,5, Gordon Schiff9,10.   

Abstract

PURPOSE: The incorporation of medication indications into the prescribing process to improve patient safety is discussed.
SUMMARY: Currently, most prescriptions lack a key piece of information needed for safe medication use: the patient-specific drug indication. Integrating indications could pave the way for safer prescribing in multiple ways, including avoiding look-alike/sound-alike errors, facilitating selection of drugs of choice, aiding in communication among the healthcare team, bolstering patient understanding and adherence, and organizing medication lists to facilitate medication reconciliation. Although strongly supported by pharmacists, multiple prior attempts to encourage prescribers to include the indication on prescriptions have not been successful. We convened 6 expert panels to consult high-level stakeholders on system design considerations and requirements necessary for building and implementing an indications-based computerized prescriber order-entry (CPOE) system. We summarize our findings from the 6 expert stakeholder panels, including rationale, literature findings, potential benefits, and challenges of incorporating indications into the prescribing process. Based on this stakeholder input, design requirements for a new CPOE interface and workflow have been identified.
CONCLUSION: The emergence of universal electronic prescribing and content knowledge vendors has laid the groundwork for incorporating indications into the CPOE prescribing process. As medication prescribing moves in the direction of inclusion of the indication, it is imperative to design CPOE systems to efficiently and effectively incorporate indications into prescriber workflows and optimize ways this can best be accomplished.
Copyright © 2018 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Entities:  

Keywords:  CPOE; drug safety; medication errors; patient safety; patient-centered care; prescription drug indications

Mesh:

Year:  2018        PMID: 29674327     DOI: 10.2146/ajhp170346

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  10 in total

1.  Understanding CancelRx: Results of End-to-End Functional Testing, Proactive Risk Assessment, and Pilot Implementation.

Authors:  Samantha I Pitts; Noah Barasch; Andrew T Maslen; Bridgette A Thomas; Leonard P Dorissaint; Krista G Decker; Sadaf Kazi; Yushi Yang; Allen R Chen
Journal:  Appl Clin Inform       Date:  2019-05-22       Impact factor: 2.342

2.  Pharmacists' perspectives on the value of reason for use information.

Authors:  Colin Whaley; Ashley Bancsi; Catherine Burns; Kelly Grindrod
Journal:  Can Pharm J (Ott)       Date:  2020-08-18

3.  Medication management surrounding transitions of care: A qualitative assessment of community pharmacists' preferences (MEMO TOC).

Authors:  Miranda Hambrook; Shaylee Peterson; Sean Gorman; Greg Becotte; Andrea Burrows
Journal:  Can Pharm J (Ott)       Date:  2020-08-27

4.  Evaluating Providers' Prescription Opioid Instructions to Pediatric Patients.

Authors:  Denise D Tran; Patrick C M Brown; Corrin Murphy; Diana Ho; Karen A Hudson; Anna C Wilson; Sarah W Feldstein Ewing
Journal:  Children (Basel)       Date:  2022-05-11

5.  Improved antibiotic prescribing using indication-based clinical decision support in the emergency department.

Authors:  Foster R Goss; Kelly Bookman; Michelle Barron; Daniel Bickley; Brady Landgren; Miranda Kroehl; Kayla Williamson; Richard Zane; Jennifer Wiler
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-03-13

6.  How do I keep myself safe? Patient perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis.

Authors:  Colin Whaley; Ashley Bancsi; Joanne Man-Wai Ho; Catherine M Burns; Kelly Grindrod
Journal:  J Pharm Policy Pract       Date:  2020-10-07

7.  Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems.

Authors:  Pamela M Garabedian; Adam Wright; Isabella Newbury; Lynn A Volk; Alejandra Salazar; Mary G Amato; Aaron W Nathan; Katherine J Forsythe; William L Galanter; Kevin Kron; Sara Myers; Joanna Abraham; Sarah K McCord; Tewodros Eguale; David W Bates; Gordon D Schiff
Journal:  JAMA Netw Open       Date:  2019-03-01

8.  2019 John M. Eisenberg Patient Safety and Quality Awards: An Interview with Gordon D. Schiff.

Authors:  Interviewed By Mark L Graber
Journal:  Jt Comm J Qual Patient Saf       Date:  2020-04-29

Review 9.  Including the Reason for Use on Prescriptions Sent to Pharmacists: Scoping Review.

Authors:  Kathryn Mercer; Caitlin Carter; Catherine Burns; Ryan Tennant; Lisa Guirguis; Kelly Grindrod
Journal:  JMIR Hum Factors       Date:  2021-11-25

10.  Incorporating 'reason for use' into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium.

Authors:  Marijke Peeters; Elias Iturrospe; Dominique Jans; Alexander L N van Nuijs; Hans De Loof
Journal:  BMC Health Serv Res       Date:  2022-09-30       Impact factor: 2.908

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.